- Home
- DXCM vs IFF Comparison
DXCM vs IFF Comparison
Compare DXCM & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- IFF
- Stock Information
- Founded
- DXCM 1999
- IFF 1833
- Country
- DXCM United States
- IFF United States
- Employees
- DXCM N/A
- IFF N/A
- Industry
- DXCM Medical/Dental Instruments
- IFF Major Chemicals
- Sector
- DXCM Health Care
- IFF Industrials
- Exchange
- DXCM Nasdaq
- IFF Nasdaq
- Market Cap
- DXCM 31.7B
- IFF 19.6B
- IPO Year
- DXCM 2005
- IFF N/A
- Fundamental
- Price
- DXCM $76.44
- IFF $63.32
- Analyst Decision
- DXCM Strong Buy
- IFF Strong Buy
- Analyst Count
- DXCM 19
- IFF 14
- Target Price
- DXCM $99.89
- IFF $92.25
- AVG Volume (30 Days)
- DXCM 4.5M
- IFF 1.9M
- Earning Date
- DXCM 10-23-2025
- IFF 11-04-2025
- Dividend Yield
- DXCM N/A
- IFF 2.52%
- EPS Growth
- DXCM N/A
- IFF N/A
- EPS
- DXCM 1.43
- IFF N/A
- Revenue
- DXCM $4,300,800,000.00
- IFF $11,303,000,000.00
- Revenue This Year
- DXCM $17.03
- IFF N/A
- Revenue Next Year
- DXCM $15.59
- IFF N/A
- P/E Ratio
- DXCM $53.42
- IFF N/A
- Revenue Growth
- DXCM 9.30
- IFF N/A
- 52 Week Low
- DXCM $57.52
- IFF $62.33
- 52 Week High
- DXCM $93.25
- IFF $106.77
- Technical
- Relative Strength Index (RSI)
- DXCM 44.18
- IFF 35.07
- Support Level
- DXCM $75.39
- IFF $63.97
- Resistance Level
- DXCM $78.96
- IFF $66.54
- Average True Range (ATR)
- DXCM 2.36
- IFF 1.40
- MACD
- DXCM 0.01
- IFF -0.01
- Stochastic Oscillator
- DXCM 36.35
- IFF 1.36
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About IFF International Flavors & Fragrances Inc.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.